Click Here to Download PDF Version
Assessment of Survival and Cardiotoxicity of Adjuvant Trastuzumab among HER2 Breast Cancer Patients in an Oncology Centre in Malaysia
- Hits: 655
PREVIOUS ISSUE |
JUNE 2018
VOLUME 3 ISSUE 1
https://doi.org/10.24191/jchs.v3i1
VOLUME 3 ISSUE 1 (S)
https://doi.org/10.24191/jchs.v3i1(S)
Click Here to Download PDF Version